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Animal models of type 2 diabetes exhibit reduced peroxisome proliferator-activated 
receptor γ coactivator-1α (PGC-1α) mRNA levels, which are associated with decreased 
oxidative capacity, in skeletal muscles. In contrast, animal models with metabolic syndrome 
show normal PGC-1α mRNA levels. We hypothesized that a high-fat diet decreases PGC-1α 
mRNA levels in skeletal muscles of rats with metabolic syndrome, reducing muscle oxidative 
capacity and accelerating metabolic syndrome or inducing type 2 diabetes. We examined 
mRNA levels and fiber profiles in the soleus muscles of rats with metabolic syndrome 
(SHR/NDmcr-cp [cp/cp], CP) fed a high-fat diet. Five-week-old CP rats were assigned to a 
sedentary group (CP-N) that was fed a standard diet (3.60 kcal/g, 23.6% protein, 5.3% fat, 
and 54.4% carbohydrates) or a sedentary group (CP-H) that was fed a high-fat diet (5.16 
kcal/g, 23.6% protein, 34.9% fat, and 25.9% carbohydrates) and were housed for 10 weeks. 
Body weight, caloric intake, and systolic blood pressure were higher in the CP-H group than 
in the CP-N group. Nonfasting glucose, triglyceride, total cholesterol, and leptin levels were 
higher in the CP-H group than in the CP-N group. There was no difference in insulin levels 
between the CP-N and CP-H groups. Muscle PGC-1α mRNA levels and succinate 
dehydrogenase activity were lower in the CP-H group than in the CP-N group. We concluded 
that a high-fat diet reduces PGC-1α mRNA levels and oxidative capacity in skeletal muscles 
and accelerates metabolic syndrome. 
 




Metabolic syndrome is characterized by obesity, high blood pressure, increased glucose 
levels, and dyslipidemia [1]. Skeletal muscle is the major site of insulin action and glucose 
metabolism. Reduced oxidative capacity in the skeletal muscles of humans and animal 
models with metabolic syndrome is known to impair glucose metabolism and increase the 
risk of the development of lifestyle-related disease, for example, type 2 diabetes and its 
complications [2]. The skeletal muscles of patients with type 2 diabetes exhibit a lower 
percentage of high-oxidative fibers than those of healthy individuals [3–6]. Similarly, the 
skeletal muscles of rats with type 2 diabetes have a lower oxidative capacity and contain a 
lower percentage of high-oxidative fibers than those of nondiabetic rats [7–10]. These results 
indicate that type 2 diabetes is associated with reduced oxidative capacity in skeletal muscles. 
Previous studies [11–16] have established that nuclear receptors such as peroxisome 
proliferator-activated receptors (PPARs) and estrogen-related receptors (ERRs), along with 
the coregulator PPAR coactivator-1α (PGC-1α), control diverse aspects of aerobic 
metabolism, including fatty acid oxidation, oxidative phosphorylation, and mitochondrial 
biogenesis, in skeletal muscles. The properties of skeletal muscle fibers, including type 
distribution and oxidative enzyme activity, are regulated by PGC-1α [11–13]. Our previous 
studies [14,15] showed that rats with type 2 diabetes have lower PGC-1α mRNA levels in the 
slow soleus and fast plantaris muscles than nondiabetic rats. Therefore, we concluded that 
reduced PGC-1α mRNA levels in the skeletal muscles of rats with type 2 diabetes are 
associated with a low percentage of high-oxidative fibers. ERRγ, which is a constitutively 
active orphan nuclear receptor, is highly expressed in tissues with high metabolic activity, for 
example, heart, kidney, brown adipose tissue, and skeletal muscle, especially the slow muscle 
[16]. ERRγ regulates mitochondria, increasing the number of mitochondria and their 
oxidative capacity in skeletal muscles by mediating the action of PGC-1α. 
We hypothesized that a high-fat diet decreases PGC-1α mRNA levels in the skeletal 
muscles of humans and animal models with metabolic syndrome, reducing muscle oxidative 
capacity. If this is true, the risk of inducing lifestyle-related diseases would be higher when 
humans and animal models with metabolic syndrome continuously consume a high-fat diet. 
In the present study, we examined the mRNA levels of genes related to glucose and lipid 
metabolism and fiber profiles, including type distribution, cross-sectional area, and oxidative 
enzyme activity, in the soleus muscles of rats with metabolic syndrome that were fed a 
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high-fat diet. We used SHR/NDmcr-cp [cp/cp] (CP) rats as an animal model of metabolic 
syndrome. CP rats have a nonsense mutation in the leptin receptor gene [17,18] and develop 
obesity, high blood pressure, increased glucose levels, hyperinsulinemia, and dyslipidemia as 
adults. 
 
2. Methods and materials 
2.1. Animals and experimental procedures 
All experimental procedures and animal care were conducted in accordance with the 
Guide for the Care and Use of Laboratory Animals published by the US National Institute of 
Health. This study was approved by the Institutional Animal Care and Experiment Committee 
of Kyoto University (Kyoto, Japan). 
Five-week-old male CP rats were divided into 2 groups: sedentary, fed a standard diet 
(CP-N; n = 6) and sedentary, fed a high-fat diet (CP-H; n = 6). Age-matched male 
Wistar-Kyoto rats fed a standard diet were used as nonobese controls (WKY; n = 6). All rats 
were obtained from Japan SLC Inc. (Hamamatsu, Japan). The nonpurified standard diet 
comprised 23.6% protein, 5.3% fat, and 54.4% carbohydrates and provided 3.6 kcal/g (MF; 
Oriental Yeast Co. Ltd., Tokyo, Japan), while the high-fat diet comprised 23.6% protein, 
34.9% fat, and 25.9% carbohydrates and provided 5.16 kcal/g (Test Diet 58Y1, rodent 
purified diet with 60% energy from fat; PMI Nutrition International, Richmond, IN). Food 
and water were provided ad libitum, and the food and caloric intakes of each rat were 
measured daily (every 24 h). All rats were housed in individual, uniformly sized standard 
cages. The room was maintained under a controlled 12-h light/dark cycle (lights were on 
from 08:00 to 20:00 h) at 22 ± 2°C with 45–55% relative humidity. Body weight and systolic 
and diastolic blood pressures of rats in all groups were measured at 5, 7, 9, 11, 13, and 15 
weeks of age. Systolic and diastolic blood pressures were determined automatically in 
conscious rats using the indirect tail-cuff method with a BP-98A sphygmomanometer 
(Softron Inc., Tokyo, Japan). 
 
2.2. Blood glucose analysis 
Fasting glucose levels were measured at 5, 7, 9, 11, 13, and 15 weeks of age after a 15-h 
fast. Blood samples were obtained from the tail veins of fully conscious rats and were 
analyzed using a portable glucose meter (GT-1650; Arkray Inc., Kyoto, Japan). Nonfasting 
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glucose levels were also measured at 15 weeks of age using the same glucose meter. 
 
2.3. Serum biochemical measurements 
All rats at 15 weeks of age were fasted for 15 h before blood sampling. Blood samples 
were obtained from the abdominal aorta under pentobarbital sodium anesthesia (5 mg/100 g 
body weight, i.p.). Serum triglyceride and total cholesterol levels were measured by routine 
laboratory methods. Serum insulin, leptin, and high molecular-weight adiponectin levels were 
measured using enzyme-linked immunosorbent assay (ELISA) kits for rats (Shibayagi Co. 
Ltd., Shibukawa, Japan). 
 
2.4. Biochemical analysis of the muscle 
The soleus muscles of both legs were dissected, and the muscle wet weight was 
measured. After muscle dissection, the rats were killed by overdose of pentobarbital sodium. 
The right soleus muscle was divided into distal and proximal parts for biochemical and 
histochemical analyses, respectively. The distal part of the right muscle was immediately 
frozen and homogenized in 5 volumes of ice-cold 0.3 M phosphate buffer (pH 7.4) using a 
glass tissue homogenizer. Sodium succinate was added to yield a final concentration of 17 
mM. The final concentrations of the components in the reaction mixture were as follows: 
sodium succinate, 17 mM; sodium cyanide (NaCN), 1 mM; aluminum chloride (AlCl3), 0.4 
mM; and calcium chloride (CaCl2), 0.4 mM. The reduction of cytochrome c in the reaction 
mixture was analyzed spectrophotometrically by observing an increase in extinction at 550 
nm. Succinate dehydrogenase (SDH) activity, an indicator of mitochondrial oxidative 
capacity, was calculated from ferricytochrome c concentrations and protein content [19]. 
 
2.5. Analysis of mRNA expression in the muscle 
Total RNA was extracted from the left soleus muscle using TRIzol Reagent (Invitrogen, 
Carlsbad, CA) and then treating samples with deoxyribonuclease I (Invitrogen). The first 
strand of cDNA was synthesized from 1.0 µg of total RNA using the PrimeScript RT reagent 
kit (Takara Bio Inc., Otsu, Japan). We analyzed gene expression by real-time polymerase 
chain reaction (RT-PCR) using a LightCycler DX400 system (Roche Diagnostics, Mannheim, 
Germany) with SYBR Premix Ex Taq II (Takara Bio Inc.). The mRNA levels of PPARδ/β, 
PGC-1α, stearoyl-CoA desaturase-1 (SCD-1), and glucose transporter 4 (GLUT4) were 
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normalized to hypoxanthine phosphoribosyltransferase (HPRT) mRNA expression. The 
primer sets for PPARδ/β, PGC-1α, and SCD-1 were described previously [14,15]. GLUT4 
primers were as follows: forward, 5′-CAACTGGACCTGTAACTTCATCGT-3′ and reverse: 
5′-ACGGCAAATAGAAGGAAGACGTA-3′. 
 
2.6. Histochemical analysis of muscle tissues 
The proximal part of the right soleus muscle was pinned to a corkboard and rapidly 
frozen in isopentane cooled with a mixture of dry ice and acetone. The muscle was mounted 
on a specimen chuck with Tissue-Tek OCT compound (Sakura Finetechnical Co. Ltd., Tokyo, 
Japan). Serial transverse 10-μm thick sections were cut using a cryostat at –20°C. Different 
fiber types were classified on the basis of ATPase activity [20]. The sections were allowed to 
reach room temperature, air dried for 30 min, and pre-incubated in alkaline (pH 10.4) or 
acidic (pH 4.5) solution for subsequent assessment of ATPase activity. The muscle fibers in 
each section were classified as type I (ATPase-positive with pre-incubation at pH 4.5 and 
ATPase-negative with pre-incubation at pH 10.4), type IIA (ATPase-negative with 
pre-incubation at pH 4.5 and ATPase-positive with pre-incubation at pH 10.4), and type IIC 
(ATPase-positive with pre-incubation at pH 4.5 and 10.4). A single common area was 
selected from each section and digitized as gray level images by using a computer-assisted 
image processing system (Neuroimaging System Inc., Kyoto, Japan). The fiber 
cross-sectional area was measured by tracing the outline of each fiber in the section. Fiber 
type distribution and cross-sectional area were determined for approximately 500 fibers 
located in the central region of the muscle section. 
The sections were also stained for 10 min to quantify SDH intensity [20]. SDH intensity 
was quantified for approximately 500 fibers described above using a computer-assisted image 
processing system (Neuroimaging System Inc.). Sectional images were digitized as gray scale 
images. Each pixel was quantified as one of 256 gray levels: gray level 0 was equivalent to 
100% light transmission and gray level 255 was equivalent to 0% light transmission. The 
mean optical density (OD) of all pixels (which were converted to gray level values) within a 
fiber was determined using a calibration photographic tablet with 21 steps of gradient-density 





2.7. Statistical analyses 
All measured values are presented as mean and standard deviation. One-way analysis of 
variance (ANOVA) was used to evaluate mean differences among the age-matched groups. 
When the differences were found to be significant by ANOVA, further comparisons were 
made using Scheffé’s post hoc test. A probability level of 0.05 was accepted as significant. 
 
3. Results 
3.1. Body weight 
Body weight at 11–15 weeks was higher in the CP-N group than in the age-matched 
WKY group (Fig. 1A). Body weight at 7 weeks was higher in the CP-H group than in the 
age-matched WKY group. Furthermore, body weight at 9–15 weeks was higher in the CP-H 
group than in the age-matched WKY and CP-N groups. 
 
Fig. 1. Body weights (A), food (B) and caloric (C) 
intakes, systolic (D) and diastolic (E) blood pressures, 
and fasting glucose levels (F) in the WKY, CP-N, and 
CP-H groups. Data are presented as the mean ± standard 
deviation (n = 6). SBP, systolic blood pressure; DBP, 
diastolic blood pressure. aP < 0.05, compared to the 
age-matched WKY group; bP < 0.05, compared to the 
age-matched WKY and CP-N groups; ; cP < 0.05, 
compared to the age-matched WKY and CP-H groups. 
 
3.2. Food and caloric intake 
Food intake at 5–7 weeks was higher in the CP-N group than in the age-matched WKY 
and CP-H groups (Fig. 1B). Food intake at 9–15 weeks was higher in the CP-N group than in 
the age-matched WKY group. Food intake at 5–15 weeks was higher in the CP-H group than 
in the age-matched WKY group. 
Caloric intake at 5–15 weeks was higher in the CP-N group than in the age-matched 
WKY group (Fig. 1C). Caloric intake at 5–9 weeks was higher in the CP-H group than in the 
age-matched WKY group. Furthermore, caloric intake at 11–15 weeks was higher in the 




3.3. Blood pressure 
Systolic blood pressure at 9–15 weeks was higher in the CP-N group than in the 
age-matched WKY group (Fig. 1D). Systolic blood pressure at 5–13 weeks was higher in the 
CP-H group than in the age-matched WKY group. Furthermore, systolic blood pressure at 15 
weeks was higher in the CP-H group than in the age-matched WKY and CP-N groups. 
Diastolic blood pressure at 11–15 weeks was higher in the CP-N group than in the 
age-matched WKY group (Fig. 1E). Diastolic blood pressure at 9–15 weeks was higher in the 
CP-H group than in the age-matched WKY group. 
 
3.4. Blood glucose levels 
Fasting glucose levels at 5–7 weeks were higher in the CP-N and CP-H groups than in 
the age-matched WKY group (Fig. 1F). Nonfasting glucose levels at 15 weeks were higher in 
the CP-N group than in the age-matched WKY group (Fig. 2A). Nonfasting glucose levels at 
15 weeks were higher in the CP-H group than in the age-matched WKY and CP-N groups. 
 
Fig. 2. Nonfasting glucose (A), triglyceride (B), total 
cholesterol (C), insulin (D), leptin (E), and adiponectin 
(F) levels in the WKY, CP-N, and CP-H groups. Data 
are presented as the mean ± standard deviation (n = 6). 
aP < 0.05, compared to the WKY group; bP < 0.05, 




3.5. Serum biochemical parameters 
Triglyceride (Fig. 2B) and leptin (Fig. 2E) levels were higher in the CP-N group than in 
the WKY group. Triglyceride and leptin levels were higher in the CP-H group than in the 
WKY and CP-N groups. Total cholesterol levels were higher in the CP-H group than in the 
WKY and CP-N groups (Fig. 2C). Insulin levels were higher (Fig. 2D) and adiponectin levels 
were lower (Fig. 2F) in the CP-N and CP-H groups than in the WKY group. 
 
3.6. Soleus muscle weight and SDH activity 
Muscle weight was lower in the CP-N and CP-H groups than in the WKY group (Fig. 3A). 
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Muscle SDH activity was lower in the CP-N group than in the WKY group (Fig. 3B). Muscle 
SDH activity was lower in the CP-H group than in the WKY and CP-N groups. 
 
Fig. 3. Soleus muscle weights (A), SDH activities (B), 
PPARδ/β (C), PGC-1α (D), SCD-1 (E), and GLUT4 (F) 
mRNA levels, fiber type percentages (G), fiber 
cross-sectional areas (H), and fiber SDH intensities (I) 
in the WKY, CP-N, and CP-H groups. Data are 
presented as the mean ± standard deviation (n = 6). 
SDH, succinate dehydrogenase; PPARδ/β, peroxisome 
proliferator-activated receptor δ/β; PGC-1α, PPAR 
coactivator-1α; SCD-1, stearoyl-CoA desaturase-1; 
GLUT4, glucose transporter 4; CSA, cross-sectional 
area. aP < 0.05, compared to the WKY group; bP < 0.05, 
compared to the WKY and CP-N groups. 
 
3.7. Soleus muscle mRNA levels 
PPARδ/β mRNA levels were lower (Fig. 3C) and the SCD-1 mRNA levels were higher 
(Fig. 3E) in the CP-N and CP-H groups than in the WKY group. PGC-1α mRNA levels were 
lower in the CP-H group than in the WKY and CP-N groups (Fig. 3D). GLUT4 mRNA levels 
were lower in the CP-H group than in the WKY group (Fig. 3F). 
 
Fig. 4. Serial transverse sections of the soleus muscles 
in WKY (A–C), CP-N (D–F), and CP-H (G–I) rats 
stained for ATPase activity after pre-incubation at pH 
10.4 (A, D, and G) or pH 4.5 (B, E, and H) and for 
SDH activity (C, F, and I). 1, type I; 2, type IIA; 3, type 





3.8. Soleus muscle fiber profiles 
Muscles in the WKY, CP-N, and CP-H groups contained 3 types of fibers: type I, IIA, 
and IIC (Fig. 4). Percentage of type I fibers was lower while percentage of type IIA fibers 
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was higher in the CP-N and CP-H groups than in the WKY group (Fig. 3G). Cross-sectional 
areas of type I, IIA, and IIC fibers were lower in the CP-N and CP-H groups than in the 
WKY group (Fig. 3H). SDH intensity of type IIA fibers was lower in the CP-N and CP-H 
groups than in the WKY group (Fig. 3I). 
 
4. Discussion 
4.1. Animal model of metabolic syndrome 
Metabolic syndrome is characterized by obesity, high blood pressure, increased glucose 
levels, and dyslipidemia [1]. In the present study, CP rats with metabolic syndrome (CP-N 
and CP-H) showed greater body weight (Fig. 1A), higher systolic (Fig. 1D) and diastolic 
(Fig. 1E) blood pressures, and increased nonfasting glucose (Fig. 2A) and triglyceride (Fig. 
2B) levels than normal rats (WKY). Furthermore, CP rats exhibited a lower soleus muscle 
weight than WKY rats (Fig. 3A). It is likely that the decreased soleus muscle weight of CP 
rats was due to atrophy of all types of muscle fibers (Fig. 3H). Although we did not measure 
the spontaneous motor activities of individual rats in the present study, this type of atrophy is 
known to be associated with the lower motor activity levels induced by obesity. The soleus 
muscle is an antigravity muscle that is persistently active; therefore, the fiber sizes are more 
susceptible to decreased muscle activity and loading levels. Our previous study [14] observed 
that CP rats were inactive in their cages all day long, except when they ate, probably due to 
their excess body weight. 
PPARδ/β is the main transcription factor that regulates fatty acid oxidation in skeletal 
muscle and adipose tissue and activates lipid metabolism to prevent obesity [21]. The reduced 
PPARδ/β mRNA levels in the skeletal muscles of CP (CP-N and CP-H) rats (Fig. 3C) may 
have induced a decreased capacity for fatty acid oxidation. A previous study [22] showed that 
hypertriglyceridemia and hyperinsulinemia were associated with increased SCD-1 activity. 
Therefore, the hypertriglyceridemia (Fig. 2B) and hyperinsulinemia (Fig. 2D) observed in CP 
rats may be associated with the increase in SCD-1 mRNA levels (Fig. 3E), which were 8.7- 
and 7.5-fold higher in CP-N and CP-H rats than in WKY rats, respectively. 
 
4.2. Effects of a high-fat diet on metabolic syndrome 
In rats, a high-fat diet stimulates tyrosine-kinase activity and reduces 
autophosphorylation of the β-subunit of the insulin receptor in the liver [23–25]. 
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Furthermore, in vitro exposure of isolated hepatocytes to free fatty acids causes a 
dose-dependent decrease in cell-surface insulin receptor binding along with diminished 
receptor-mediated internalization and degradation [24,26]. A reduction in insulin action in the 
liver leads to decreased inhibition of hepatic glucose output. On the other hand, the oxidative 
stress pathway responsible for the production of reactive oxygen species is upregulated in 
both liver and adipose tissue of mice fed a high-fat diet before the onset of insulin resistance 
and obesity [27]. These results indicate that liver and adipose tissue are important in the 
maintenance of glucose and lipid metabolism and that a condition of excessive nutrient intake 
induces and accelerates insulin resistance and enhances oxidative stress levels. Insulin 
resistance has been recognized as the integral feature of metabolic syndrome, which includes 
glucose intolerance, hypertriglyceridemia, low HDL-cholesterol, and hypertension. In the 
present study, we investigated PGC-1α mRNA levels and oxidative capacity of the soleus 
muscles in rats with metabolic syndrome because a high-fat diet may have significant effects 
on the skeletal muscles of rats with metabolic syndrome as well as on liver and adipose 
tissue. 
In CP (CP-N and CP-H) rats, CP-H rats exhibited a greater body weight (Fig. 1A), higher 
systolic blood pressure (Fig. 1D), and increased nonfasting glucose (Fig. 2A) and triglyceride 
(Fig. 2B) levels than CP-N rats, while there was no difference in insulin levels between CP-N 
and CP-H rats (Fig. 2D). The insulin signaling pathway may be downregulated in CP-H rats, 
and decreased phosphorylation of the insulin receptor and insulin receptor substrate (IRS)-1 
may be present, although this was not investigated in the present study. These results indicate 
that a high-fat diet accelerates metabolic syndrome. Insulin and leptin stimulate the 
sympathetic nervous system, and this contributes to increased blood pressure [28]. CP-H rats 
had higher systolic blood pressure (Fig. 1D) and leptin levels (Fig. 2E) than CP-N rats, 
suggesting that the increased leptin levels in CP-H rats may contribute to higher blood 
pressure. 
In the present study, CP-H rats showed higher insulin levels than WKY rats (Fig. 2D), 
suggesting that these rats were still able to produce insulin at this stage. However, 
continuation of increased caloric intake under the influence of metabolic syndrome may have 
resulted in decreased insulin levels because the pancreas may have exhausted its ability to 
produce the large amounts of insulin required for continued hyperinsulinemia. This decrease 
in insulin levels would eventually lead to the development of type 2 diabetes. 
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ERRγ is exclusively expressed in the slow muscle [16], indicating that there is an ERRγ 
pathway that promotes and coordinates vascular supply and metabolic demand in the slow 
muscle. In a previous study [29], mice that transgenically overexpressed ERRγ in the fast 
muscle exhibited high running endurance, resistance to diet-induced weight gain, increased 
oxygen consumption, enhanced oxidative capacity, dense vasculature, and increased 
expression of genes promoting fat metabolism, mitochondrial respiration, and high-oxidative 
fiber specification. These results indicate that transgenic expression of ERRγ in the fast 
muscle triggers an anaerobic to aerobic transformation and vascular remodeling to enhance 
aerobic capacity. In addition, the intrinsic effects of ERRγ do not depend on PGC-1α 
induction, but rather are associated with ERRγ-directed adenosine monophosphate-activated 
protein kinase (AMPK) activation in skeletal muscles [29]. 
Multiple diseases, including metabolic syndrome and type 2 diabetes, are commonly 
linked to deregulation of both oxidative metabolism and vascularity. In skeletal muscles, 
oxidative capacity is an important factor influencing the progression or prevention of 
lifestyle-related diseases, for example, type 2 diabetes [14,15]. In the present study, we 
focused on PGC-1α mRNA levels and oxidative capacity in the skeletal muscles of rats with 
metabolic syndrome fed a high-fat diet. A previous study [11] observed that PGC-1α mRNA 
levels in skeletal muscles were associated with oxidative capacity; enhanced PGC-1α mRNA 
levels induced an increased percentage of high-oxidative fibers in skeletal muscles, while 
reduced PGC-1α mRNA levels induced a decreased percentage of high-oxidative fibers. In 
our previous studies [14,15], we observed that the slow soleus and fast plantaris muscles of 
rats with type 2 diabetes exhibited lower PGC-1α mRNA levels than normal rats and rats with 
metabolic syndrome, whereas there were no differences in PGC-1α mRNA levels in the 
skeletal muscles of normal rats and rats with metabolic syndrome. These results indicated that 
rats with metabolic syndrome maintain normal PGC-1α mRNA levels, while those with type 
2 diabetes show reduced PGC-1α mRNA levels, inducing decreased muscle oxidative 
capacity. In the present study, we hypothesized that a high-fat diet induces the decrease in 
PGC-1α mRNA levels in the skeletal muscles of animal models with metabolic syndrome, 
leading to reduced muscle oxidative capacity. Our present data support this hypothesis; 
decreased PGC-1α mRNA levels (Fig. 3D) and reduced oxidative enzyme activity (Fig. 3B) 




4.3. Limitations of the present study 
In the present study, we used CP rats having a nonsense mutation in the leptin receptor 
[17,18]. The results obtained by this animal model cannot be directly applied to humans, 
although profiles of metabolic syndrome, for example, obesity, high blood pressure, 
increased glucose levels, and dyslipidemia, are similar in CP rats and humans. 
Although previous investigations using several animal models have studied the 
traditional high-fat diet in animal models of diet-induced obesity, comparison of this high-fat 
diet to diets consisting of food regularly consumed by humans, including high-salt, high-fat, 
low-fiber, and energy dense foods, are lacking. In the “cafeteria diet” model [30,31], animal 
are allowed free access to standard chow and water while highly palatable, energy-dense, and 
unhealthy human foods are offered concurrently. This diet promotes rapid weight gain, 
increased fat mass, and enhanced prediabetic parameters, including glucose and insulin 
intolerance [32–34]. Since diet-induced obesity in animal models is a commonly used tool to 
support clinical research in humans, further experiments using an alternative dietary model of 
energy-dense and highly palatable cafeteria-style foods in animal models would be useful. 
In conclusion, while the development and progression of metabolic syndrome depends 
on genetic background, it is also highly influenced by daily lifestyle. Increased energy intake 
is the major cause of decreased PGC-1α mRNA levels and oxidative capacity in skeletal 
muscles, and this accelerates metabolic syndrome and eventually induces type 2 diabetes. 
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